Oric Pharmaceuticals, Inc. ORIC
Oric Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 6,572,691 | $53.8M | 6.67% |
| BlackRock Finance, Inc. | 4,830,880 | $34.2M | 4.9% |
| CITADEL ADVISORS LLC | 2,432,741 | $30.8M | 2.47% |
| AQR CAPITAL MANAGEMENT LLC | 170,087 | $2.2M | 0.17% |
| D. E. Shaw & Co., Inc. | 44,390 | $562,421 | 0.05% |
| MILLENNIUM MANAGEMENT LLC | 34,012 | $430,932 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.